Original Article
Copyright ©2010 Baishideng.
World J Gastroenterol. May 28, 2010; 16(20): 2484-2495
Published online May 28, 2010. doi: 10.3748/wjg.v16.i20.2484
Table 5 Follow-up study
Case No.Main medicationDietary pattern
Days of remissionReason for terminationOn final attendance
Month 3Year 1Year 2On relapseCDAICRP (mg/dL)BMI (kg/m2)Alb (g/dL)Chol (mg/dL)ChE (IU/mL)Hemoglobin (g/dL)
1SSZ for 1 yrSVDSVDSVD730Completion00.123.14.5235568414.4
2MesalamineSVDOmniOmni301Relapse1938.217.53.8151326213.8
3MesalamineSVDOmniOmni367Relapse16711.321.13.5133355110.0
4MesalamineSVDSVDSVD730Completion1285.018.72.811411139.3
5SSZ for 1 yrSVDSVD523Moving39019.44.5194550915.0
6MesalamineOmniOmni191Relapse1925.721.73.913430527.9
7NoneSVDSVD442INFX for RA612.019.64.0158506810.9
8MesalamineSVDSVDSVD635Relapse1747.619.13.188267811.3
9MesalamineOmniOmniOmni730Completion480.219.84.3171546115.2
10MesalamineSVDSVDSVD730Completion180.118.25.1181465916.3
11MesalamineSVDSVDSVD730Completion11019.74.7147521513.9
12MesalamineSVDSVDSVD730Completion45020.24.7163626811.3
13MesalamineSVDSVDSVD730Completion0022.84.6171477015.6
14MesalamineSVDSVD666Ongoing270.119.34.7188608415.1
15MesalamineSVDOmni560Ongoing0022.64.8185567116.8
16MesalamineSVDSVD440Ongoing191.921.84.4141514614.2
17MesalamineSVDSVD397Ongoing322.022.53.6216268311.1
18MesalamineSVDSVDSVD730Completion250.422.63.71511022211.1
19MesalamineSVDSVDSVD730Completion62020.14.7139439113.3
20NoneSVDSVDSVD730Completion370.718.24.5156565513.2
21SSZSVDSVDSVD730Completion160.119.04.9205642414.4
22MesalamineSVDOmniOmni630Relapse1185.122.13.584359610.1